Mice Model Market (Microinjection, Embryonic Stem Cell) worth $1,819.9 Million by 2018 - New Report by MarketsandMarkets
(PRWEB) April 14, 2014 -- This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018”, The market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.
Browse 116 market data tables and 85 figures spread through 339 pages and in-depth TOC on "Mice Model Market"
http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html
Early buyers will receive 10% customization on this report.
Ask for Free Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1308.
The global mice model market is categorized into four broad segments, namely, by type, by technology, by disease, and by service. The mice model market, by type, comprises of inbred, outbred, congenic/hybrid, surgically modified, knockout, and spontaneous mutant mice. The market for technology is segmented into microinjection, embryonic stem cell technique, virus/vector, nuclear transferase, genetically modified sperm, and others. By disease, the mice model market is segmented into diabetes, CNS, oncology, cardiovascular, immunology and inflammation, metabolism and regulation, and others. The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The report also includes the mice care products market, which includes cages, feed, bedding, and others.
Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1308.
The expanding global biotechnology and pharmaceutical industries and increasing government investments, funds, and grants have stimulated the usage of advanced mice models in the biotechnology and pharmaceutical industries. Furthermore, research activities in the fields of cancer, HIV, and diabetes have increased the application areas of mice models. Various factors such as technological advancements, incessant rise in new product launches, and increasing number of conferences are propelling the growth of the mice model market.
These three players and other mice model companies follow various key growth strategies, such as agreements, partnerships, collaborations, and joint ventures; licensing; grants and funds; and patents, marketing and promotional activities, new product launches and others. In terms of strategies and tactical moves, Jackson Laboratory has been the most aggressive and competent firm in the past three years. The firm has made 17 strategic developments (2010 to 2013) to fortify its foothold in the global mice model market.
Agreements, partnerships, collaborations, and joint ventures was a key strategy adopted by players, accounting for 31.6% of the total strategies from 2010 to 2013. This strategy enables companies to expand their product portfolios and customer base, increase access to each others’ complementary technologies for research activities, jointly establish facilities for the production of mice models, and co-distribute mice models to end users. Taconic Farms, Inc. (U.S.) had the highest percentage (32%) out of the total 31 agreements, partnerships, collaborations, and joint ventures-related developments witnessed by the industry (2010 to 2013). The company entered into agreements, alliances, strategic partnerships, and exclusive marketing and distribution agreements with several companies and institutes that are involved in R&D activities and that have requirements for mice models.
Browse Related Reports:
Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog@ http://www.marketsandmarketsblog.com/market-reports/healthcare
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article